1.Eating behaviors related to brucellosis infection in Mongolian middle school students in Abaga Banner, Inner Mongolia
YOU Xiang, Battle, HAO Wenli, LIU Ruijia, XU Haixia, LI Muting
Chinese Journal of School Health 2021;42(2):287-290
Objective:
To understand current situation and associated factors of brucellosis infection among students in Mongolian middle school in Abaga Banner, and to provide basis for further development of prevention and treatment strategies.
Methods:
Serological examinations were performed on pupils and middle school students in a Mongolian middle school in Abaga Banner. Questionnaire surveys were used to investigate students knowledge of eating behaviors related to brucellosis infection.
Results:
A total of 500 primary and middle school students were investigated, and 6 cases of brucellosis were confirmed, and the infection rate was 1.20%. There were 4 cases of male infection and 2 cases of female infection. The infection rate in boys (1.61%) was higher than that of girls (0.79%). Higher proportion was found in 14-year-old group (n=3), accounting for 17.40%. The residence period of 10-15 years includes 6 cases of all infected persons. The number of infections in Narenbaolige Town was 4, accounting for 23.40%. Univariate logistic regression analysis shows that frequent consumption of unsterilized dairy products, milking, processing lambs or slugs and infected cloth The disease was positively correlated (OR=11.80, 139.14, 8.02, P<0.05). Multivariate Logistic regression analysis showed that milking was positively correlated with brucellosis infection(OR=20.19, 95%CI=2.01-202.74, P=0.01).
Conclusion
The brucellosis infection of Mongolian primary and middle school students in Abaga Banner is related to a variety of related dietary factors, and its prevention and treatment should be strengthened.
2.Advances of Claudin6-targeting drugs in cancer therapy.
Guixia LI ; Yuxin BI ; Ruijia HAO ; Xuemin ZHENG ; Genbei WANG ; Jian LI ; Pengyin WANG
Chinese Journal of Biotechnology 2023;39(4):1304-1313
CLDN6 is a member of the CLDNs family that is specifically and highly expressed in cancers such as ovarian, testicular, endocervical, liver and lung adenocarcinoma, but hardly expressed in adult normal tissues. CLDN6 is able to activate multiple signaling pathways, which take part in the development and progression of cancer, including promoting tumor growth, migration and invasion, and promoting chemoresistance in cancer. In recent years, CLDN6 has received much attention as a novel target for cancer therapeutics. Many types of anticancer drugs targeting CLDN6 have been developed, including antibody-conjugated drugs (ADC), monoclonal antibodies, bispecific antibodies, and chimeric antigen receptor T-cell immunotherapy (CAR-T). This paper briefly summarizes the structure, expression and function of CLDN6 in tumors, and reviews the current status and ideas of developing targeted CLDN6 anticancer drugs.
Signal Transduction
;
Immunotherapy
;
Antibodies, Monoclonal
;
Neoplasms/drug therapy*
3.Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice.
Xiaoqing LI ; Xinxin LI ; Genbei WANG ; Yan XU ; Yuanyuan WANG ; Ruijia HAO ; Xiaohui MA
Frontiers of Medicine 2018;12(6):688-696
Xiao Ke Qing (XKQ) granule has been clinically used to treat type 2 diabetes mellitus (T2DM) for 10 years in Chinese traditional medication. However, its mechanisms against hyperglycemia remain poorly understood. This study aims to investigate XKQ mechanisms on diabetes and diabetic liver disease by using the KKAy mice model. Our results indicate that XKQ can significantly reduce food and water intake. XKQ treatment also remarkably decreases both the fasting blood glucose and blood glucose in the oral glucose tolerance test. Additionally, XKQ can significantly decrease the serum alanine aminotransferase level and liver index and can alleviate the fat degeneration in liver tissues. Moreover, XKQ can ameliorate insulin resistance and upregulate the expression of IRS-1, PI3K (p85), p-Akt, and GLUT4 in the skeletal muscle of KKAy mice. XKQ is an effective drug for T2DM by ameliorating insulin resistance and regulating the PI3K/Akt signaling pathway in the skeletal muscle.
Animals
;
Blood Glucose
;
drug effects
;
metabolism
;
Diabetes Mellitus, Type 2
;
drug therapy
;
metabolism
;
Disease Models, Animal
;
Drugs, Chinese Herbal
;
pharmacology
;
Female
;
Glucose Tolerance Test
;
Glucose Transporter Type 4
;
metabolism
;
Hypoglycemic Agents
;
pharmacology
;
Insulin
;
blood
;
Insulin Resistance
;
Liver
;
drug effects
;
pathology
;
Mice
;
Mice, Inbred C57BL
;
Phosphatidylinositol 3-Kinases
;
metabolism
;
Proto-Oncogene Proteins c-akt
;
metabolism
;
Signal Transduction
;
drug effects